European Archives - Page 1063 of 1132 - European Medical Journal

EMJ

Dr Anne Armstrong and Prof Nigel Bundred discuss genomic profiling of breast cancer

Anne Armstrong, MRCP, PhD, MB ChB, BSc(Hons), of The Christie Hospital, Manchester, UK, and Nigel Bundred, MD, FRCS, of The University of Manchester, UK…

EMJ

Adjuvant therapy for early stage ER-positive, HER2-negative invasive breast cancer

Hope S. Rugo, MD, of UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, shares her experience on the recommended treatment approach…

EMJ

Phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Nicholas Turner, MD, PhD, of the Institute of Cancer Research and Royal Marsden…

EMJ

ESC Congress 2015 Hot Lines to Reveal the Latest in CVD Research

Sophia Antipolis, 23 July 2015 – Six hot line sessions at ESC Congress 2015 are set to reveal the latest in cardiovascular disease research across a…

EMJ

Gilead Announces Phase 3 Results from the First Study to Evaluate Switching from TDF-Based Regimens to a TAF-Based Regimen Containing Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide (E/C/F/TAF)

VANCOUVER, July 21, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced detailed 48 week data from an open-label Phase 3 study (Study 109)…

EMJ

New Therapy for Polycystic Kidney Disease

TECHNIQUE for treating polycystic kidney disease (PKD) has been revealed by researchers at The University of Manchester and University College London (UCL).

EMJ

Signal Discovered that Induces Lone Kidney Growth when other is Lost

ENLARGEMENT of a lone kidney following the loss of its partner has finally been explained, as scientists have identified a signal that could be…

Supporting CKD Patients at Home

Dr Heaf opened the symposium by welcoming the attendees and introducing the speakers. Prof Cowie explained the concept of remote monitoring and outlined…

The Ongoing Management of Hyperkalaemia in Chronic Kidney Disease Patients: Cases for Clinical Decisions

This educational symposium provided an insight into the most current clinical evidence of the efficacy and safety of renin—angiotensin—aldosterone system…

Renal Transplantation in Autosomal Dominant Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 1 in 1,000 people in the general population. The natural history of ADPKD…